157 related articles for article (PubMed ID: 6306685)
1. The regulation of a cellular protein, p53, in normal and transformed cells.
Levine AJ; Reich N; Thomas R
Prog Clin Biol Res; 1983; 119():159-69. PubMed ID: 6306685
[No Abstract] [Full Text] [Related]
2. Growth-dependent expression of human Mr 53,000 tumor antigen messenger RNA in normal and neoplastic cells.
Calabretta B; Kaczmarek L; Selleri L; Torelli G; Ming PM; Ming SC; Mercer WE
Cancer Res; 1986 Nov; 46(11):5738-42. PubMed ID: 3019534
[TBL] [Abstract][Full Text] [Related]
3. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells].
Kakpakova ES
Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520
[TBL] [Abstract][Full Text] [Related]
4. Simian virus 40-coded antigens and the detection of a 55K-dalton cellular protein in early embryo cells.
Mora PT; Chandrasekaran K
Biomembranes; 1983; 11():259-84. PubMed ID: 6299418
[No Abstract] [Full Text] [Related]
5. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
6. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
Müller E; Boldyreff B; Scheidtmann KH
Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
8. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
9. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
Tiemann F; Deppert W
Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity.
Klinger HP
Birth Defects Orig Artic Ser; 1982; 18(2):68-84. PubMed ID: 7159710
[No Abstract] [Full Text] [Related]
11. [Genetic nature of neoplastic transformation].
Shapot VS; Likhtenshteĭn AV
Tsitol Genet; 1978; 12(1):73-84. PubMed ID: 356361
[TBL] [Abstract][Full Text] [Related]
12. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
13. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
Damo LA; Snyder PW; Franklin DS
Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of integration of monkey adenovirus SA7 DNA fragments with genomes of transformed and tumoral cells].
Chaplygina NM; Gartel' AL; Ponomareva TI; Tiunnikov GI; Tikhonenko TI
Vopr Med Khim; 1983; 29(3):14-22. PubMed ID: 6308902
[TBL] [Abstract][Full Text] [Related]
15. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
[TBL] [Abstract][Full Text] [Related]
16. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
17. The transformation-related p53 protein: a potential regulator of cell proliferation.
Mercer WE; Baserga R
Prog Clin Biol Res; 1985; 177():171-91. PubMed ID: 2409558
[No Abstract] [Full Text] [Related]
18. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
McKendrick L; Meek DW
Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
[TBL] [Abstract][Full Text] [Related]
19. Human tumor suppressor p53 and DNA viruses.
Collot-Teixeira S; Bass J; Denis F; Ranger-Rogez S
Rev Med Virol; 2004; 14(5):301-19. PubMed ID: 15334538
[TBL] [Abstract][Full Text] [Related]
20. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.
Salewski H; Bayer TA; Eidhoff U; Preuss U; Weggen S; Scheidtmann KH
Cancer Res; 1999 Apr; 59(8):1980-6. PubMed ID: 10213510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
